R2030429 |
4-[4-(1-Hydroxyethyl)-2-Methoxy-5-nitrophenoxy]butanoic Acid |
|
R2030430 |
Cyanine3 carboxylic acid |
|
R2030431 |
Cy3.5-COOH |
|
R2030432 |
Cyanine5.5 carboxylic acid |
|
R2030433 |
Cyanine5 carboxylic acid |
|
R2030434 |
Tegafur Impurity |
|
R2030435 |
4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(piperazin-1-yl)propoxy)quinoline-3-carbonitrile |
|
R2030436 |
2-(4-benzoyl-3-hydroxyphenoxy)acetic acid |
|
R2030437 |
2-amino-6-bromo-5,6-dihydrobenzothiazol-7(4H)-one |
|
R2030438 |
3,3',5,5'-TETRA(TERT-BUTYL)[1,1'-BIPHENYL]-4,4'-DIOL |
|
R2030439 |
Benzonitrile,4,4',4''-[1,3,5-benzenetriyltris(oxy)]tris-(9CI) |
|
R2030440 |
tert-butyl N-[2-[[5-methoxy-4-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-nitrophenyl](methyl)amino]ethyl]-N-methylcarbamate |
|
R2031168 |
(R)-N-(pyrrolidin-3-ylmethyl)methanesulfonamide |
该产品曾做过需定制
|
R2003041 |
LIT-001 TFA |
LIT-001 is the first nonpeptide oxytocin receptor (OT-R) agonist (EC50=55 nM; Ki
|
R2003051 |
Cefminox sodium (MT-141) |
Cefminox sodium (MT-141) is a semisynthetic cephamycin, which exhibits a broad s
|
R2003081 |
SRT3025 HCl;Sirtuin modulator 1 |
Sirtuin modulator 1 is a modulator of SIRTl, a homolog of SIRT3, with EC1.5 of &
|
R00391 |
Safinamide (FCE 26743) |
Safinamide (FCE 26743) selectively and reversibly inhibits MAO-B with IC50 of 98
|
R00310 |
Nilotinib Impurity 9 |
Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineop
|
R00311 |
Cardiogenol C, Hydrochloride |
Cardiogenol C hydrochloride is a cell-permeable pyrimidine compound which potent
|
R00313 |
Cisplatin (CDDP; cis-Diaminodichloroplatinum) |
Cisplatin is a antineoplastic chemotherapy drug which works by cross-linking wit
|
R00314 |
Defactinib |
Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antian
|
R00315 |
Defactinib hydrochloride;VS-6063 hydrochloride; PF 04554878 hydrochloride |
Defactinib hydrochloride (VS-6063 hydrochloride; PF 04554878 hydrochloride) is a
|
R00318 |
Donepezil;E2020 free base |
Donepezil (E2020 free base) is a specific and potent AChE inhibitor with IC50s o
|
R00320 |
olodaterol hydrochloride |
Olodaterol hydrochloride is the hydrochloride salt form of Olodaterol, which is
|
R00321 |
RET-IN-1 |
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A
|